WBSCR17-AUTS2 Fusion FISH Probe
The WBSCR17-AUTS2 Fusion FISH Probe is used to confirm a fusion of the WBSCR17 and AUTS2 genes. The fusion of the WBSCR17 and AUTS2 genes has been associated with Uterine Carcinosarcoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| WBSCR17-AUTS2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| WBSCR17-AUTS2-20-AQAQ | 20 (40 μL) | 200 μL |
|
AUTS2 Gene Summary
This gene has been implicated in neurodevelopment and as a candidate gene for numerous neurological disorders, including autism spectrum disorders, intellectual disability, and developmental delay. Mutations in this gene have also been associated with non-neurological disorders, such as acute lymphoblastic leukemia, aging of the skin, early-onset androgenetic alopecia, and certain cancers. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, May 2014]
Gene Name: AUTS2, Activator Of Transcription And Developmental Regulator
Chromosome: CHR7: 69063905 -70257885
Locus: 7q11.22
Gene Diseases
The WBSCR17 AUTS2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Uterine Carcinosarcoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|